Division of Infectious Diseases & Environmental Medicine
Leadership
Name:
John Zurlo, MD
Position:
Director, Division of Infectious Diseases
Email:
John.Zurlo@jefferson.edu
Contact
Name:
Division of Infectious Disease & Environmental Medicine
1101 Market Street
Suite 2720
Philadelphia, PA 19107
Contact Number(s):
- 215-955-7785
- 215-955-9362 (fax)
Research Activities
Publications
- Rideshare services for transportation assistance in gynecologic oncology: a quality improvement study
- “Anything can happen”: experiences of people using opioids in a xylazine market
- Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China
- Breast cancer survival rates and determinants in Ethiopia: a systematic review and meta-analysis of longitudinal studies
- 5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies
- Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis
- Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women
- Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge
- Macular Thinning and Microvasculature Abnormalities in Children with Sickle Cell Disease: A Longitudinal Analysis
- Beyond smoking: A geospatial investigation of factors associated with lung and bronchus cancer risk in Pennsylvania
- Representation of Women Authors in 4 Decades of Rugby Research
- Primary Care Use and Clinical Outcomes Among Patients Initiating Hemodialysis
- Effects of Implementing a Standardized Risk Stratification and Triage Workflow for an Established Pulmonary Embolism Response Team
- Associations between widowhood status/duration, depression, and cognitive function among community-dwelling Indians age 60 years or older: Exploration of sex and residential factors
- Amputation trends among people who use drugs in the context of Philadelphia's increasingly xylazine adulterated drug supply
- Race, Ethnicity, and Gender Differences in Patient Reported Well-Being and Cognitive Functioning Within 3 Months of Symptomatic Illness During COVID-19 Pandemic
- Evidence and Consensus-based Imaging Guidelines in Birdshot Chorioretinopathy: Multimodal Imaging in Uveitis (MUV) Taskforce Report 8
- Parenting through the eyes of mothers with substance use disorder: Implications for treatment and related services
- REAL-WORLD ASSOCIATIONS between GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USE and DIABETIC RETINOPATHY ACCOUNTING for LONGITUDINAL GLYCEMIC CONTROL
- A Hybrid Deep Learning–Based Approach for Visual Field Test Forecasting